|
End-of-day quote
Nasdaq
04/09/2026
|
5-day change | 1st Jan Change | ||
| 1.020 USD | +38.02% |
|
+56.25% | -98.69% |
| 09-01 | White House Cuts Deal to Lower Prescription Drug Prices With Nine Companies | MT |
| 08-13 | Onconetix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 | CI |
| Market Cap | 3.32M 2.85M 2.68M 2.45M 4.57M 314M 4.59M 31.79M 12.3M 161M 12.46M 12.18M 512M | P/E 2024 * |
-
| P/E 2025 | -0.09x |
|---|---|---|---|---|---|
| Enterprise Value | -1.85M -1.59M -1.5M -1.37M -2.55M -176M -2.57M -17.77M -6.88M -89.87M -6.96M -6.81M -286M | EV / Sales 2024 |
5,556,319x | EV / Sales 2025 | -3,367,890x |
| Free-Float |
99.83% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| ONCO | End-of-day quote | |
CBOE
| ONCO | Real-time |
Last Transcript : Onconetix, Inc.
| 1 day | +38.02% | ||
| 1 week | +56.25% | ||
| Current month | +62.73% | ||
| 1 month | +14.40% | ||
| 3 months | +0.99% | ||
| 6 months | -95.82% | ||
| Current year | -98.69% |
| 1 week | 0.66 |  | 1.05 |
| 1 month | 0.59 | | 1.05 |
| Current year | 0.59 | | 115 |
| 1 year | 0.59 | | 209.5 |
| 3 years | 0.59 | | 132,581.94 |
| 5 years | 0.59 | | 15,452,876.38 |
| 10 years | 0.59 | | 15,452,876.38 |
| Manager | Title | Age | Since |
|---|---|---|---|
David White
CEO | Chief Executive Officer | 73 | 18/03/2026 |
Karina Fedasz
CEO | Chief Executive Officer | 53 | 02/04/2025 |
| Director | Title | Age | Since |
|---|---|---|---|
Simon Tarsh
BRD | Director/Board Member | 64 | 01/08/2022 |
Sarah Romano
BRD | Director/Board Member | 46 | 05/12/2025 |
Sammy Dorf
CHM | Chairman | 41 | 23/04/2026 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 4/14/26 A | HRT Financial LP
| Sell | Company | 49,710 | 7.1739% | |
| 4/14/26 A | HRT Financial LP
| Other | Company | 104,498 | 15.0807% | |
| 4/14/26 A | HRT Financial LP
| Sell | Company | 182,965 | 26.4047% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +38.02% | +56.25% | -99.24% | -100.00% | 3.32M | |
| -2.10% | -1.64% | +45.10% | -2.45% | 80.91B | |
| -0.78% | -1.52% | -18.45% | -36.25% | 60.46B | |
| -3.59% | -9.04% | +465.16% | +30.37% | 56.02B | |
| -1.77% | -5.26% | -9.16% | +29.36% | 49.63B | |
| -0.68% | -6.85% | -1.77% | +149.21% | 45.88B | |
| -3.77% | -1.64% | +50.34% | -17.95% | 31.4B | |
| -1.85% | -0.49% | +43.72% | +94.44% | 25.22B | |
| -2.05% | -3.63% | -2.78% | +156.14% | 22.25B | |
| -1.27% | -0.66% | +63.41% | +103.79% | 16.59B | |
| Average | +2.01% | +4.88% | +53.63% | +40.66% | 38.84B | |
| Weighted average by Cap. | -1.99% | -1.44% | +81.71% | +37.66% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 2.52 2.17 2.04 1.86 3.48 239.3 3.5 24.19 9.36 122.31 9.48 9.27 389.22 | 0.82 0.7 0.66 0.6 1.12 77.3 1.13 7.81 3.02 39.51 3.06 2.99 125.73 |
| Net income | -58.69M -50.46M -47.47M -43.32M -80.85M -5.56B -81.27M -563M -218M -2.84B -220M -216M -9.05B | -14.03M -12.07M -11.35M -10.36M -19.33M -1.33B -19.43M -134M -52.03M -680M -52.69M -51.54M -2.16B |
| Net Debt | 8.8M 7.57M 7.12M 6.5M 12.12M 834M 12.19M 84.35M 32.63M 426M 33.05M 32.33M 1.36B | -5.17M -4.45M -4.18M -3.82M -7.12M -490M -7.16M -49.57M -19.18M -251M -19.42M -19M -798M |
Employees
-
Sector
Pharmaceuticals
| Date | Price | Change | Volume |
|---|---|---|---|
| 08/09/26 | $0.8400 | -17.65% | 1,261,950 |
| 04/09/26 | $1.020 | +38.02% | 6,663,281 |
| 03/09/26 | $0.7390 | +9.60% | 289,127 |
| 02/09/26 | $0.6743 | +3.29% | 98,324 |
| 01/09/26 | $0.6528 | +4.15% | 127,315 |
- Stock Market
- Stocks
- ONCO Stock
Select your edition
All financial news and data tailored to specific country editions
